{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:42:01Z","timestamp":1792600921777,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10461-026-05062-0","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T08:50:07Z","timestamp":1772959807000},"page":"2384-2393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rapid Identification of HIV Among People Who Inject Drugs: Tampa, FL, 2024"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0168-0734","authenticated-orcid":false,"given":"Bernice","family":"McCoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4291-5802","authenticated-orcid":false,"given":"Jason","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-7339","authenticated-orcid":false,"given":"Asa","family":"Oxner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Mutchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Carlesso-Dager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EmmyLou","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"issue":"1","key":"5062_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540121.2024.2354897","volume":"36","author":"K Mckinnon","year":"2024","unstructured":"Mckinnon K, Myers JJ, Larkin C. Barriers and facilitators to implementing evidence-based integrated HIV and behavioral health care: perspectives from seven federal ending the HIV epidemic jurisdictions. AIDS Care. 2024;36(1):1\u20138. https:\/\/doi.org\/10.1080\/09540121.2024.2354897.","journal-title":"AIDS Care"},{"key":"5062_CR2","doi-asserted-by":"publisher","unstructured":"Sokoloff B. Ending the HIV epidemic: A plan for America. In: Hardy D, editor. Fundamentals of HIV Medicine: 2023 Edition. Oxford Academic; 2023. p. 1\u20135. https:\/\/doi.org\/10.1093\/med\/9780197679098.003.0001.","DOI":"10.1093\/med\/9780197679098.003.0001"},{"key":"5062_CR3","unstructured":"CDC. Syringe Services Programs. Retrieved from CDC HIV.\u00a02024;\u00a0https:\/\/www.cdc.gov\/hiv\/effective-interventions\/prevent\/syringe-services-programs\/index.html"},{"issue":"3","key":"5062_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11904-018-0396-x","volume":"15","author":"K Rich","year":"2018","unstructured":"Rich K, Bia J, Altice F, Feinberg J. Integrated models of care for individuals with opioid use disorder: how do we prevent HIV and HCV? Curr HIV AIDS Rep. 2018;15(3):266\u201375. https:\/\/doi.org\/10.1007\/s11904-018-0396-x.","journal-title":"Curr HIV AIDS Rep"},{"key":"5062_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00515-2","author":"C Franco","year":"2021","unstructured":"Franco C, Lee-Winn A, Brandspigel S, Alishahi M, Brooks-Russell A. We\u2019re actually more of a likely ally than an unlikely ally\u201d: relationships between syringe services programs and law enforcement. Harm Reduct J. 2021. https:\/\/doi.org\/10.1186\/s12954-021-00515-2.","journal-title":"Harm Reduct J"},{"key":"5062_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RC Fernandes","year":"2017","unstructured":"Fernandes RC. Effectiveness of needle and syringe programmes in people who inject drugs: an overview of systematic reviews. BMC Public Health. 2017;17:309. https:\/\/doi.org\/10.1186\/s12889-017-4210-2.","journal-title":"BMC Public Health"},{"issue":"9","key":"5062_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD012021.pub2","volume":"2017","author":"LM Platt","year":"2017","unstructured":"Platt LM. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;2017(9):1\u201380. https:\/\/doi.org\/10.1002\/14651858.CD012021.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"5062_CR8","unstructured":"CDC. Undetectable\u2009=\u2009Untransmittable (U\u2009=\u2009U). Retrieved October 2024, from centers for disease control and prevention (2022). https:\/\/www.cdc.gov\/hiv\/basics\/livingwithhiv\/undetectable.html"},{"issue":"11","key":"5062_CR9","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2105\/ajph.85.11.1531","volume":"85","author":"H Hagan","year":"1995","unstructured":"Hagan H, Jarlais DCD, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995;85(11):1531\u20137. https:\/\/doi.org\/10.2105\/ajph.85.11.1531.","journal-title":"Am J Public Health"},{"issue":"9033","key":"5062_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s0140-6736(96)02536-6","volume":"348","author":"DCD Jarlais","year":"1996","unstructured":"Jarlais DCD, Marmor M, Paone D, Titus S, Shi Q, Perlis T, Friedman SR. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348(9033):987\u201391. https:\/\/doi.org\/10.1016\/s0140-6736(96)02536-6.","journal-title":"Lancet"},{"issue":"5","key":"5062_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0277-9536(94)00435-v","volume":"41","author":"GV Stimson","year":"1995","unstructured":"Stimson GV. AIDS and injecting drug use in the United Kingdom, 1987\u20131993: the policy response and the prevention of the epidemic. Soc Sci Med. 1995;41(5):699\u2013716. https:\/\/doi.org\/10.1016\/0277-9536(94)00435-v.","journal-title":"Soc Sci Med"},{"issue":"2","key":"5062_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jama.1994.03510260047027","volume":"271","author":"JK Watters","year":"1994","unstructured":"Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV\/AIDS prevention for injection drug users. JAMA. 1994;271(2):115\u201320.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"5062_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-019-0711-z","volume":"16","author":"SM Ay\u00f3n","year":"2019","unstructured":"Ay\u00f3n SM, Jeneby F, Hamid F, Badhrus A, Abdulrahman T, Mburu G. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs. Reprod Health. 2019;16(Suppl 1):71. https:\/\/doi.org\/10.1186\/s12978-019-0711-z.","journal-title":"Reprod Health"},{"issue":"1","key":"5062_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12954-017-0179-5","volume":"14","author":"CN Behrends","year":"2017","unstructured":"Behrends CN, Morabia A, Kamarulzaman A. Implementation of buprenorphine services in New York City syringe services programs: a qualitative process evaluation. Harm Reduct J. 2017;14(1):52.","journal-title":"Harm Reduct J"},{"key":"5062_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/hiv.12493","volume":"18","author":"L Ti","year":"2017","unstructured":"Ti L, Dong H, Kerr T, Turje R, Parashar S, Min J, Montaner J, Wood E, Milloy M-J. The effect of engagement in an HIV\/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis. HIV Med. 2017;18:580\u20136. https:\/\/doi.org\/10.1111\/hiv.12493.","journal-title":"HIV Med"},{"issue":"6","key":"5062_CR16","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2105\/AJPH.2019.305515","volume":"24","author":"DC Des Jarlais","year":"2020","unstructured":"Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K. Expansion of syringe service programs in the United States, 2015\u20132018. AIDS Behav. 2020;24(6):1895\u2013902. https:\/\/doi.org\/10.2105\/AJPH.2019.305515.","journal-title":"AIDS Behav"},{"key":"5062_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00439-5","volume":"17","author":"N Farhadian","year":"2022","unstructured":"Farhadian N, Karami Matin B, Farnia V, et al. The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis. Subst Abuse Treat Prev Policy. 2022;17:11. https:\/\/doi.org\/10.1186\/s13011-022-00439-5.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"8","key":"5062_CR18","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s10461-024-04369-0","volume":"28","author":"I Sokale","year":"2024","unstructured":"Sokale I, Wilkerson J, Wermuth P, Atem F, Burnett J, Wejnert C, Kuo I. Past-year HIV testing, current antiretroviral therapy use, and participation in services for people who inject drugs. AIDS Behav. 2024;28(8):2793\u2013803. https:\/\/doi.org\/10.1007\/s10461-024-04369-0.","journal-title":"AIDS Behav"},{"issue":"4","key":"5062_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/qad.0b013e3283437c2b","volume":"25","author":"SJ Reynolds","year":"2011","unstructured":"Reynolds SJ, Makumbi F, Nakigozi G, Kagaayi J, Gray RH, Wawer M, et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS. 2011;25(4):473\u20137. https:\/\/doi.org\/10.1097\/qad.0b013e3283437c2b.","journal-title":"AIDS"},{"issue":"3","key":"5062_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/nejmoa1814556","volume":"381","author":"R Hayes","year":"2019","unstructured":"Hayes R, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Fidler S. Effect of universal testing and treatment on HIV incidence. New Engl J Med. 2019;381(3):207\u201318. https:\/\/doi.org\/10.1056\/nejmoa1814556.","journal-title":"New Engl J Med"},{"issue":"6","key":"5062_CR21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/qad.0000000000001039","volume":"30","author":"DC DeJarlais","year":"2016","unstructured":"DeJarlais DC, Kerr T, Carrieri P, Feelemyer J, Arasteh K. Hiv infection among persons who inject drugs. AIDS. 2016;30(6):815\u201326. https:\/\/doi.org\/10.1097\/qad.0000000000001039.","journal-title":"AIDS"},{"key":"5062_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa112","author":"SB Lyss","year":"2020","unstructured":"Lyss SB, Buchacz K, McClung RP, et al. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs\u2014United States, 2016\u20132019: perspectives on recent experience and lessons learned. J Infect Dis. 2020. https:\/\/doi.org\/10.1093\/infdis\/jiaa112.","journal-title":"J Infect Dis"},{"key":"5062_CR23","unstructured":"Broz D, Spiller M, Wejnert C, Bailey GP. Syringe services program coverage, HIV risk behaviors and prevention services among persons who inject drugs, 20 cities in the United States. Presented at: APHA Annual Meeting; 2017. Available from: https:\/\/apha.confex.com\/apha\/2017\/meetingapi.cgi\/Session\/50328?filename=2017_Session50328.pdf&template=Word. Accessed January 26, 2021."},{"key":"5062_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104\u201310. https:\/\/doi.org\/10.1016\/j.drugpo.2018.04.004.","journal-title":"Int J Drug Policy"},{"key":"5062_CR25","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/cid\/ciz321","volume":"70","author":"WC Goedel","year":"2020","unstructured":"Goedel WC, King MRF, Lurie MN, et al. Implementation of syringe services programs to prevent rapid human immunodeficiency virus transmission in rural counties in the United States: a modeling study. Clin Infect Dis. 2020;70:1096\u2013102. https:\/\/doi.org\/10.1093\/cid\/ciz321.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5062_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, Walters SM, Ezell JM, Ompad DC. They look at us like junkies: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):1\u20139. https:\/\/doi.org\/10.1186\/s12954-020-00399-8.","journal-title":"Harm Reduct J"},{"key":"5062_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08582-z","author":"A Mathews","year":"2020","unstructured":"Mathews A, Farley S, Conserve DF, Knight K, Alston L, Blumberg M, Blow S, Jennings L, Tucker JD. Meet people where they are: A qualitative study of community barriers and facilitators to HIV testing and HIV self-testing among African Americans in urban and rural areas in North Carolina. BMC Public Health. 2020. https:\/\/doi.org\/10.1186\/s12889-020-08582-z.","journal-title":"BMC Public Health"},{"issue":"2","key":"5062_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/jnc.0000000000000391","volume":"34","author":"N Ghalekhani","year":"2023","unstructured":"Ghalekhani N, Mirzazadeh A, Tavakoli F, Mousavian G, Khezri M, Zamani O, et al. HIV continuum of care among people who inject drugs in iran: a cross-sectional study. J Assoc Nurses AIDS Care. 2023;34(2):182\u20137. https:\/\/doi.org\/10.1097\/jnc.0000000000000391.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"6","key":"5062_CR29","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.jana.2012.09.003","volume":"24","author":"A Asher","year":"2013","unstructured":"Asher A, Hahn JA, Couture M, Maher K, Page K. People who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013;24(6):e35\u201344. https:\/\/doi.org\/10.1016\/j.jana.2012.09.003.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"42","key":"5062_CR30","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.15585\/mmwr.mm7042a1","volume":"70","author":"S Handanagi\u0107","year":"2021","unstructured":"Handanagi\u0107 S. HIV infection and HIV-associated behaviors among persons who inject drugs \u2014 23 metropolitan statistical areas, united States, 2018. MMWR Morb Mortal Wkly Rep. 2021;70(42):1459\u201365. https:\/\/doi.org\/10.15585\/mmwr.mm7042a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5062_CR31","doi-asserted-by":"publisher","DOI":"10.21203\/rs.2.18608\/v3","author":"LC Dengo-Baloi","year":"2020","unstructured":"Dengo-Baloi LC, Boothe M, Baltazar CS, Sathane I, Langa DC, Condula M, Horth R. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment. AIDS Behav. 2020. https:\/\/doi.org\/10.21203\/rs.2.18608\/v3.","journal-title":"AIDS Behav"},{"issue":"2","key":"5062_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/JAN.0000000000000522","volume":"34","author":"JD Champion","year":"2023","unstructured":"Champion JD. An assessment of HIV risk, perceptions of risk, and potential adherence to preexposure prophylaxis among HIV-negative people with injection drug use who access mobile outreach services. J Addict Nurs. 2023;34(2):101\u201310. https:\/\/doi.org\/10.1097\/JAN.0000000000000522.","journal-title":"J Addict Nurs"},{"key":"5062_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.21149\/spm.v57s2.7597","volume":"57","author":"RF Armenta","year":"2015","unstructured":"Armenta RF, Abramovitz D, Lozada R, Vera A, Garfein RS, Magis-Rodr\u00edguez C, Strathdee SA. Correlates of perceived risk of HIV infection among persons who inject drugs in Tijuana, Baja California, Mexico. Salud Publica Mex. 2015;57:107. https:\/\/doi.org\/10.21149\/spm.v57s2.7597.","journal-title":"Salud Publica Mex"},{"key":"5062_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00881-z","author":"M Khezri","year":"2023","unstructured":"Khezri M. Awareness and willingness to use HIV self-testing among people who inject drugs in Iran. Harm Reduct J. 2023. https:\/\/doi.org\/10.1186\/s12954-023-00881-z.","journal-title":"Harm Reduct J"},{"issue":"1","key":"5062_CR35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/10530789.2021.1892931","volume":"31","author":"R Marcus","year":"2021","unstructured":"Marcus R, Cha S, Sion\u00e9an C, Kanny D. HIV injection risk behaviors among HIV-negative people who inject drugs experiencing homelessness, 23 U.S. cities. J Soc Distress Homeless. 2021;31(1):96\u2013104. https:\/\/doi.org\/10.1080\/10530789.2021.1892931.","journal-title":"J Soc Distress Homeless"},{"issue":"S3","key":"5062_CR36","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1086\/651477","volume":"50","author":"IV Bassett","year":"2010","unstructured":"Bassett IV, Walensky RP. Integrating HIV screening into routine health care in resource-limited settings. Clin Infect Dis. 2010;50(S3):S77\u201384. https:\/\/doi.org\/10.1086\/651477.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5062_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11904-022-00614-0","volume":"19","author":"QR Soh","year":"2022","unstructured":"Soh QR, Oh LYJ, Chow EPF, Johnson C, Jamil MS, Ong JJ. HIV testing uptake according to opt-in, opt-out or risk-based testing approaches: a systematic review and meta-analysis. Curr HIV\/AIDS Rep. 2022;19(5):375\u201383. https:\/\/doi.org\/10.1007\/s11904-022-00614-0.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"5062_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/23259582211041260","author":"P Eckardt","year":"2021","unstructured":"Eckardt P, Niu J, Montalvo S. Emergency room \u201copt-out\u201d HIV testing pre- and during COVID-19 pandemic in a large community health system. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2021. https:\/\/doi.org\/10.1177\/23259582211041260.","journal-title":"Journal of the International Association of Providers of AIDS Care (JIAPAC)"},{"key":"5062_CR39","unstructured":"CDC. Opt-Out HIV\/HCV Screening. Retrieved. October 9, 2024, from Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention. 2024;\u00a0https:\/\/www.cdc.gov\/hiv\/research\/interventionresearch\/compendium\/index.html"},{"key":"5062_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108344","volume":"127","author":"T Bartholomew","year":"2021","unstructured":"Bartholomew T, Feaster D, Patel H, Forrest D, Tookes H. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida. J Subst Abuse Treat. 2021;127:108344. https:\/\/doi.org\/10.1016\/j.jsat.2021.108344.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"5062_CR41","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.2105\/AJPH.2011.300460","volume":"102","author":"LR Metsch","year":"2012","unstructured":"Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, Miles CC, Rodriguez AE, Vargo S, Colfax GN. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160\u20137. https:\/\/doi.org\/10.2105\/AJPH.2011.300460.","journal-title":"Am J Public Health"},{"issue":"1","key":"5062_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10461-019-02680-9","volume":"24","author":"H Tookes","year":"2020","unstructured":"Tookes H, Bartholomew TS, Geary S, Matthias J, Poschman K, Blackmore C, et al. Rapid identification and investigation of an HIV risk network among people who inject drugs -Miami, FL, 2018. AIDS Behav. 2020;24(1):246\u201356. https:\/\/doi.org\/10.1007\/s10461-019-02680-9.","journal-title":"AIDS Behav"},{"issue":"11","key":"5062_CR43","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s10461-015-1097-8","volume":"19","author":"C Figueroa","year":"2015","unstructured":"Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav. 2015;19(11):1949\u201365. https:\/\/doi.org\/10.1007\/s10461-015-1097-8.","journal-title":"AIDS Behav"},{"key":"5062_CR44","doi-asserted-by":"publisher","unstructured":"Tookes HE, Oxner A, Serota DP, Alonso E, Metsch LR, Feaster DJ, Ucha J, Suarez E Jr, Forrest DW, McCollister K, Rodriguez A, Kolber MA, Chueng TA, Zayas S, McCoy B, Sutherland K, Archer C, Bartholomew TS. Project T-SHARP: study protocol for a multi-siterandomized controlled trial of tele-harm reduction for people with HIV who inject drugs. Trials. 2023;24:96.https:\/\/doi.org\/10.1186\/s13063-023-07074-w.","DOI":"10.1186\/s13063-023-07074-w"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05062-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:02:02Z","timestamp":1792598522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05062-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5062"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05062-0","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"31 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The article Rapid Identification of HIV Among People Who Inject Drugs: Tampa, FL, 2024, written by Bernice McCoy\u00b7 Jason Wilson \u00b7 Asa Oxner \u00b7 Alexa Mutchler \u00b7 Maria Carlesso-Dager\u00b7 EmmyLou Fuchs \u00b7 Emily Holbrook \u00b7 Heather Henderson was originally published open access under a \u201cCreative Commons Attribution Non-Commercial (CC BY-NC 4.0)\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board at the University of South Florida determined that the study met criteria for exemption from IRB review and qualified for a waiver of signed authorization under the HIPAA Privacy Rule (45 CFR 164.512(i)).","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Verbal consent for HIV testing was obtained as part of routine clinical care. Data used in this study were de-identified prior to analysis to protect participant anonymity.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}